Patient-centred evaluation of a reduced dose of botulinum toxin A in the management of myofascial pain
In our previous service evaluation, we reported improvement in patients’ pain scores for masseteric pain and spasm, following injection of 50 units of botulinum toxin A (BtA), measured using visual analogue scales (VAS). We have recently introduced a lower dose BtA protocol, for appropriately select...
Saved in:
Main Authors: | Alice Cameron, Simon Haworth, Jerry N. Farrier |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2025-03-01
|
Series: | Advances in Oral and Maxillofacial Surgery |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S2667147625000020 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Retrospective review of dosing trends in botulinum toxin injections for the treatment of adductor spasmodic dysphonia in a long-term cohort
by: Gabrielle French, et al.
Published: (2020-01-01) -
The Effect of Different Doses of Botulinum Toxin on Masseter Muscle in Patients with Bruxism.
by: Kawa F. Dizaye, et al.
Published: (2022-02-01) -
Iatrogenic Botulism After Cosmetic Use of Botulinum Toxin‐A: A Case Series
by: Mohammad Asadi, et al.
Published: (2025-01-01) -
Botulinum toxin A as a treatment modality for acute acquired comitant esotropia – An Indian perspective
by: Akshay Badakere, et al.
Published: (2025-02-01) -
Intragastric botulinum toxin injection: a promising alternative for obesity treatment?
by: Hakan Balbaloglu, et al.
Published: (2024-10-01)